
Clinical Laboratory
RightSign COVID/Flu/RSV/Adeno Combo Test ICFRAN-MC85H/ICFRAN-MC85S
Hangzhou Biotest Biotech · ICFRAN-MC85H/ICFRAN-MC85S
Article No. AK-CL-525Product details
- Article number
- AK-CL-525
- Category
- Clinical Laboratory
- Brand
- Hangzhou Biotest Biotech
- Model
- ICFRAN-MC85H/ICFRAN-MC85S
Description
The RightSign COVID/Flu/RSV/Adeno Combo Test provides a rapid and reliable solution for the differential diagnosis of common respiratory infections using a single nasal swab. The test qualitatively detects SARS-CoV-2, Influenza A & B, RSV and Adenovirus, supporting fast clinical decision-making in medical practices, laboratories, and point-of-care settings. The test is designed for simple and efficient handling, making it well suited for routine use in busy clinical environments. All required components are included in the kit. Sample collection is performed quickly and comfortably using the sterile nasal swab, and results are available in approximately 10 minutes via visual readout. A single test covers five relevant pathogens, reducing the need for multiple swabs and helping to streamline diagnostic workflows. This improves patient comfort while supporting efficient organisation within the clinical team. The test offers high sensitivity and specificity, providing reliable support for diagnostic assessment in both symptomatic and asymptomatic patients. The RightSign Combo Test is intended for professional use, including point-of-care testing, allowing flexible integration into eve
Request a quotation
Equipment standard by AKLION — configuration, accessories and lead time are confirmed on the quotation.
Technical specifications
- Brand
- Hangzhou Biotest Biotech
- Model
- ICFRAN-MC85H/ICFRAN-MC85S
- Product type
- Point Of Care Testing Devices
- Test principle
- Qualitative, chromatographic immunoassay (lateral flow)
- Sample material
- Nasal swab
- Result display
- Visual, coloured test lines
- Evaluation time
- 10 minutes
- Test procedure
- For professional users (laboratory, daily work in a medical practice)
- COVID-19
- 100%
- Influenza A
- 100%
- Influenza B
- 100%
- RSV
- 100%
- Adenovirus
- 100%